← Back to Search

Exercise Program for Cancer Survivors (EXCEL Trial)

N/A
Recruiting
Led By Nicole Culos-Reed, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age over 18 years
About to have treatment, currently having treatment, or have had cancer treatment within the last 5 years
Must not have
Unable to participate in exercise
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to one-year
Awards & highlights
No Placebo-Only Group

Summary

This trial will provide cancer survivors in rural and remote areas with tailored exercise programs to help them manage their cancer and encourage them to become life-long exercisers.

Who is the study for?
This trial is for adults over 18 who are about to start, currently undergoing, or have completed cancer treatment within the last 5 years. Participants must be able to read/write in English and access online programs if needed. They should be capable of mild physical activity and have a diagnosis of cancer.
What is being tested?
EXCEL aims to provide community or online exercise programs specifically designed for rural and under-served cancer survivors. The goal is to help participants become life-long exercisers by offering tailored exercise opportunities that they might not otherwise have.
What are the potential side effects?
Since this trial involves group exercise classes, potential side effects may include typical risks associated with physical activity such as muscle soreness, fatigue, and the risk of injury. However, these activities are planned at mild intensity levels suitable for participants' conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I am currently undergoing, about to undergo, or have completed cancer treatment in the last 5 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot participate in physical activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Physical Activity Minutes Per Week
Secondary study objectives
Aerobic Endurance
Balance
Barriers and facilitators to exercise participation
+14 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All participants will be involved in group exercise classes, twice a week for 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group Exercise Classes
2014
N/A
~210

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
810 Previous Clinical Trials
884,815 Total Patients Enrolled
University of AlbertaOTHER
942 Previous Clinical Trials
432,909 Total Patients Enrolled
Dalhousie UniversityOTHER
173 Previous Clinical Trials
400,354 Total Patients Enrolled
Alberta Health servicesOTHER
163 Previous Clinical Trials
651,158 Total Patients Enrolled
University Health Network, TorontoOTHER
1,531 Previous Clinical Trials
502,822 Total Patients Enrolled
Memorial University of NewfoundlandOTHER
71 Previous Clinical Trials
1,834,359 Total Patients Enrolled
University of British ColumbiaOTHER
1,481 Previous Clinical Trials
2,493,416 Total Patients Enrolled
University of Prince Edward IslandOTHER
16 Previous Clinical Trials
95,788 Total Patients Enrolled
Nicole Culos-Reed, PhDPrincipal InvestigatorUniversity of Calgary
7 Previous Clinical Trials
2,903 Total Patients Enrolled
Margaret L McNeely, PhDPrincipal InvestigatorUniversity of Alberta
2 Previous Clinical Trials
140 Total Patients Enrolled

Media Library

Group Exercise Classes Clinical Trial Eligibility Overview. Trial Name: NCT04478851 — N/A
Cancer Research Study Groups: Intervention
Cancer Clinical Trial 2023: Group Exercise Classes Highlights & Side Effects. Trial Name: NCT04478851 — N/A
Group Exercise Classes 2023 Treatment Timeline for Medical Study. Trial Name: NCT04478851 — N/A
~621 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top